Stockreport

argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease

argenx SE - American Depositary Shares  (ARGX) 
PDF 15 December, 2025, 7:00 AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people [Read more]